NCT05467345View on ClinicalTrials.gov

Evaluation of the Performance of CONTOUR NEXT® and CONTOUR PLUS ELITE® BGMS in Neonates Using Capillary Blood Samples

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

August 24, 2022

Primary Completion Date

November 30, 2022

Study Completion Date

March 14, 2023

Conditions
Diabetes Mellitus
Interventions
DEVICE

Contour Next and Contour Plus Elite BGMS testing of neonatal blood

The purpose of this study is to extend the intended use of two BGMSs to include testing of neonatal blood by Health Care Professionals in a clinical setting for the quantitative measurement of glucose levels in neonates.

Trial Locations (1)

63110

St. Louis Children's Hospital, Washington University, St Louis

Sponsors
All Listed Sponsors
lead

Ascensia Diabetes Care

INDUSTRY

NCT05467345 - Evaluation of the Performance of CONTOUR NEXT® and CONTOUR PLUS ELITE® BGMS in Neonates Using Capillary Blood Samples | Biotech Hunter | Biotech Hunter